other material
confidence high
sentiment neutral
materiality 0.60
Protagenic shareholders approve reverse stock split at ratio 1:10 to 1:20
Protagenic Therapeutics, Inc.new
- Special Meeting held April 18, 2025; 4,049,963 shares present out of 7,241,443 entitled.
- Reverse split proposal passed: 3,560,865 for, 333,824 against, 155,274 abstain.
- Board authorized to choose exact ratio between 1:10 and 1:20 and timing before Jan 31, 2026.
- Adjournment proposal also approved: 3,552,086 for, 336,677 against, 161,200 abstain.